Please use this identifier to cite or link to this item:
|Title:||Access to antidiabetic treatment and patient self-monitoring|
Azzopardi, Lilian M.
|Keywords:||Diabetics -- Treatment|
Diabetics -- Attitudes
Blood sugar monitoring
Diabetics -- Malta -- Case studies
|Publisher:||University of Malta. Department of Pharmacy|
|Citation:||Zarb, J., Wirth, F., & Azzopardi, L. M. (2019, October). Access to antidiabetic treatment and patient self-monitoring. Poster session presented at the 48th ESCP Symposium on Clinical Pharmacy, Ljubljana, Slovenia.|
|Abstract:||A poster presentation regarding access to antidiabetic treatment and patient self-monitoring. Introduction: Patient self-monitoring of blood glucose (SMBG) levels contributes to patient empowerment and optimization of management of diabetes. Continuous glucose monitoring (CGM) is increasing in use and involves monitoring blood glucose levels using a continuous glucose monitor. Aims: • To investigate the perception of patients with Type 1 diabetes (T1DM) regarding SMBG and CGM; • To identify problems encountered by patients when carrying out blood glucose self-monitoring.|
|Appears in Collections:||Scholarly Works - FacM&SPha|
Files in This Item:
|Access_to_antidiabetic_treatment_and_patient_self_monitoring_2019.pdf||539.96 kB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.